Top Image Systems Completes Acquisition of Cloud Software

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Top Image Systems Completes Acquisition of Cloud Software and Solutions Company eGistics

TEL AVIV, Israel, NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) -- Top Image Systems, Ltd. (Nasdaq: TISA ) , a leading Enterprise Content Management (ECM) and Business Process Management (BPM) solutions and Mobile Imaging Platform (MIP) provider, today announced that it has completed its acquisition of eGistics, Inc. in a transaction valued at $18 million. TIS paid the purchase price 50% in cash and 50% in TIS shares.

"We are pleased to announce that we have closed on this transaction, and we are excited about the opportunity to cross-sell and integrate our complementary product portfolios to grow market share, increase revenues and strengthen our market presence," said Izhak Nakar, Founder and Active Chairman of Top Image Systems. "Our combined offering provides cutting-edge technologies that will enable more advanced next generation solutions for document and data management and content-driven business process automation. In particular, we will be better able to offer solutions leveraging the secure, on-demand cloud-based eGistics' CloudDocs framework, which offers physical and cyber security, utilizing multiple encryption technologies and best-in-class intrusion detection. Combining TIS' industry-leading enterprise capture and workflow solutions, mobile image processing platform and broad global install base with eGistics' innovative cloud-based platform and world-class clients in the U.S. financial sector make this a very valuable and positive transaction from strategic, geographic and technological as well as from financial perspectives."

Don Dixon, Managing Director and Co-Founder of Trident Capital, the largest shareholder of eGistics, has joined the TIS Board of Directors.

Canaccord Genuity acted as exclusive financial advisor to Top Image Systems in connection with the transaction and Needham & Company acted as financial advisor to eGistics. Schwell Wimpfheimer & Associates LLP and Choate Hall & Stewart LLP acted as legal advisors to Top Image Systems and Wilson Sonsini Goodrich & Rosati acted as legal advisor to eGistics.

About eGistics, Inc.

eGistics is a leading provider of private cloud solutions that streamline payments business processes. The eGistics private cloud solution automates the capture, management and delivery of documents and data in a highly secure, highly scalable and compliant environment. Today, the eGistics private cloud solution supports paper and electronic transaction processes for many of the largest financial institutions and third-party processors in the U.S. To learn more, visit www.egisticsinc.com .

About Top Image Systems

Top Image Systems™ (TIS™) Ltd. is a leading innovator of enterprise solutions for managing and validating content entering organizations from various sources. Whether originating from mobile, electronic, paper or other sources, TIS' solutions deliver content across enterprise applications. TIS' eFLOW Platform is a common platform for the company's solutions which is marketed in more than 40 countries through a multi-tier network of distributors, system integrators, value-added resellers and strategic partners. Visit the company's website at http://www.TopImageSystems.com for more information.

Caution Concerning Forward-Looking Statements

Certain matters discussed in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results expressed or implied in those forward looking statements. Words such as "will," "expects,", "anticipates," "estimates," and words and terms of similar substance in connection with any discussion of future operating or financial performance identify forward-looking statements. These statements are based on management's current expectations or beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially including, but not limited to, the ability to retain the customers, employees and business relationships of eGistics after the closing, risks in product development, approval and introduction plans and schedules, rapid technological change, customer acceptance of new products, the impact of competitive products and pricing, the lengthy sales cycle, proprietary rights of TIS and its competitors, risk of operations in Israel, government regulation, litigation, general economic conditions and other risk factors detailed in the Company's most recent annual report on Form 20-F and subsequent filings with the United States Securities and Exchange Commission. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

TIS Company Press Contact: Randy Davis eGistics, Inc. +1 214 256 4635 TIS Company Press Contact: Shelli Zargary Director of Corporate Marketing and Investor Relations, Top Image Systems Ltd. +972 3 767 9114 TIS Investors: James Carbonara Regional Vice President, Hayden IR + 1 646 755 7412

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Kal Raman Joins Photon to Drive Strategic AI Innovation Forward

Updated Category News Views 357

Kal Raman Joins Photon as Strategic Advisor to CEO Photon, a leader in digital and AI solutions, is excited to announce that Kal Raman has been appointed as a Strategic Advisor to the CEO. His primary focus will be to work closely with the executive leadership team to build strong relationships with major cloud and technology platforms in the AI ecosystem. This strategic...

Continue Reading
Fiverr's Q3 2024: Growth Strategies and Financial Insights

Updated Category News Views 319

Fiverr Reports Strong Q3 2024 Results Fiverr International Ltd. (NYSE: FVRR) has delivered impressive financial results for the third quarter of 2024. This success demonstrates the company's commitment to enhancing its services and reaching growth targets even amidst a challenging economic environment. Fiverr's strategy focuses on increasing its take rate by offering...

Continue Reading
Upcoming Legal Action for Jasper Therapeutics Investors Explained

Updated Category News Views 234

Legal Investigation Updates for Jasper Investors As the legal landscape around Jasper Therapeutics, Inc. (NASDAQ: JSPR) evolves, important updates are emerging for investors affected by recent developments. Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating claims on behalf of shareholders who may have suffered losses due to the...

Continue Reading
Naf Naf Grill Unveils Flavor-Packed Spiced Meatballs Today

Updated Category News Views 91

Introducing Spiced Meatballs at Naf Naf Grill Naf Naf Grill has just launched an exciting new dish: Spiced Meatballs. These flavorful meatballs are crafted with care to showcase the vibrant essence of Middle Eastern cuisine, making them a perfect addition to enhance your dining experience this fall. Rich Middle Eastern Flavors Made from 100% beef, these Spiced Meatballs...

Continue Reading
Pulmatrix Shares Q1 2025 Financial Results and New Directions

Updated Category News Views 170

Overview of Pulmatrix's Recent Developments Pulmatrix, Inc. is a biopharmaceutical entity focused on developing innovative inhaled therapeutic products to treat migraine and respiratory diseases, utilizing its specialized iSPERSE™ technology. In a recent announcement, the company outlined its financial performance for the first quarter of 2025. Key Financial Outcomes...

Continue Reading